Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

2016428 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Haematology

Volume 3, Issue 4, pp. e186-e195

Field-Weighted Citation Impact: 29.12